Antiplatelet Therapy in Patients With COVID-19
Because venous and arterial thromboembolism are common among patients hospitalized with COVID-19, anticoagulant therapies were among the first to be evaluated i
Leo Pharma Maastricht University Medical Center Cardiovascular Research Institute Maastricht International Society On Thrombosis Randomized Evaluation International Society
Source: jamanetwork.com